Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer screening

R M Hostetler1, I G Mandel, J Marshburn

  • 1Department of Family Medicine, University of South Florida College of Medicine, Tampa, USA.

The Medical Clinics of North America
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gaining strategic advantages through partnerships with public health departments.

Journal of health and human services administration·2001
Same author

Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma.

Surgical oncology clinics of North America·1999
Same author

Managed care organizations and mammography: opportunities to serve underserved women.

Women & health·1999
Same author

Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.

Journal of pharmaceutical sciences·1998
Same author

Meeting critical health administration education needs for the managed care environment.

The Journal of health administration education·1997
Same author

Investment in new technology research can save future health care dollars.

The Journal of the Florida Medical Association·1997
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Prostate cancer screening effectiveness remains unproven, leading to elusive optimal strategies. Further research and trials are needed to clarify treatment efficacy and understand prostate cancer as potentially multiple distinct diseases.

Area of Science:

  • Oncology
  • Urology
  • Medical Diagnostics

Background:

  • Prostate cancer is a significant cause of cancer death in men.
  • Early detection may be possible through digital rectal exam (DRE), prostate-specific antigen (PSA) testing, and transrectal ultrasound (TRUS).

Purpose of the Study:

  • To address the unproven effectiveness of prostate cancer treatments.
  • To clarify optimal screening strategies for prostate cancer.
  • To explore the possibility of prostate cancer comprising multiple distinct disease entities.

Main Methods:

  • Review of current diagnostic and screening practices.
  • Discussion of the role of informed consent in patient decision-making.
  • Reference to ongoing or future research, such as the PIVOT trial.

Related Experiment Videos

Main Results:

  • The effectiveness of prostate cancer treatments is not yet definitively proven.
  • Optimal screening strategies remain elusive due to unproven treatment efficacy.
  • Prostate cancer may represent multiple diseases with varying natural histories and treatment requirements.

Conclusions:

  • Further research, including large-scale trials, is crucial for understanding prostate cancer.
  • Clarifying treatment effectiveness is essential for developing optimal screening guidelines.
  • Informed consent is important given the controversies and uncertainties surrounding prostate cancer management.